Cargando…
Therapeutic Role of Tocilizumab in SARS-CoV-2-Induced Cytokine Storm: Rationale and Current Evidence
Among patients suffering from coronavirus disease 2019 (COVID-19) syndrome, one of the worst possible scenarios is represented by the critical lung damage caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-induced cytokine storm, responsible for a potentially very dangerous h...
Autores principales: | Pelaia, Corrado, Calabrese, Cecilia, Garofalo, Eugenio, Bruni, Andrea, Vatrella, Alessandro, Pelaia, Girolamo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002419/ https://www.ncbi.nlm.nih.gov/pubmed/33802761 http://dx.doi.org/10.3390/ijms22063059 |
Ejemplares similares
-
Lung under attack by COVID-19-induced cytokine storm:
pathogenic mechanisms and therapeutic implications
por: Pelaia, Corrado, et al.
Publicado: (2020) -
Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma
por: Pelaia, Corrado, et al.
Publicado: (2018) -
Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD
por: Pelaia, Girolamo, et al.
Publicado: (2015) -
Benralizumab in the treatment of severe asthma: design, development and potential place in therapy
por: Pelaia, Corrado, et al.
Publicado: (2018) -
Omalizumab, the first available antibody for biological treatment of
severe asthma: more than a decade of real-life effectiveness
por: Pelaia, Corrado, et al.
Publicado: (2018)